Boston's Vertex Has Taken A Roller Coaster Ride To Profitability
Along the way Vertex got a boost from a unique funding source and, as a result, developed an unusual business model.
View ArticleBiotech Startups: Dreams, Risk, Failure And — Sometimes — Success
Hundreds of startups help power the Boston area's biotech boom, but it's widely accepted that failures vastly exceed successes.
View ArticleTribes Of Kendall Square: How To Parse Who's Who In Hotbed Of Biotech
The dense Boston-area cluster of biotech has a culture and cast of characters all its own -- academics, entrepreneurs, venture capitalists -- much as Silicon Valley does.
View ArticleFrom Tough Love To Empathy: Coaching For Parents With Opioid-Addicted Children
Parents caught up in the opioid epidemic with their adult children are often advised to show "tough love." But a gentler, more collaborative method is helping some parents to help their children get...
View ArticleThis Biotech Unicorn Hopes To Revolutionize Drug Making, But It Has Its Skeptics
Investors think Moderna Therapeutics holds a lot of promise -- a new technology that could revolutionize thousands of medicines.
View ArticleOne Of Biotech's Biggest Investors Says The Industry Must Be 'Unreasonable'
Noubar Afeyan is one of biotech's most prolific investors.
View ArticleAffording Miracles: As Biotech Victories In Gene Therapy Excite, Costs Spur...
The first-approved gene therapy costs an eye-popping $142,000 per drop, helping to spur the quest to find better ways of pricing and paying for these miraculous new treatments.
View ArticleUMass Inventor Insists On Due Credit For Nurses Who Innovate
A UMass Amherst nursing professor has been named to a national panel of inventors -- the first nurse to be honored alongside engineers and computer scientists.
View ArticleNumber Of Women Leaders At Biotech Companies Lags — But Is Improving
Two leaders in biotech -- both women -- discuss how women in management benefit biotech companies, and what's being done to bring more women into executive office suites and board rooms.
View ArticleNext Chapter For Biotech? Many Say 'Convergence' With Data Science
Artificial intelligence, big data analytics and deep learning are converging on health care in a big way, experts insist.
View ArticleCould The 'BioBoom' Go Bust? How One MIT Professor Sees It
The hope and promise of lifesaving medical treatments fuel biotech investor exuberance to the tune of billions of dollars per year in Massachusetts. MIT's Andrew Lo breaks down how a biotech bubble...
View ArticleNext Era For Biotech: Designer Cells To Attack Diseases
A biotech CEO argues that the biggest news in the sector is not the creation of cures for specific diseases but rather of whole new types of treatments.
View ArticleToll Of Twitter Trolls: Study Delves Into Social Media's Link To Depression
Negative social media interactions may increase depression in young adults, but positive encounters don't prevent it, a study finds.
View ArticleMass. Sues Purdue Pharma Over 670 Residents Who Fatally Overdosed On Opioids
The state is suing Purdue Pharma on behalf of residents who were prescribed OxyContin, became addicted to opioids, overdosed and died.
View ArticleAbrupt Resignation Of Harvard Pilgrim CEO Will Have 'No Impact' On Talks With...
The abrupt resignation of Harvard Pilgrim CEO and President Eric Schultz comes during ongoing discussions with Partners HealthCare that some believe could result in a merger.
View ArticleHouse OKs Clark Bill That Would Offer Student Loan Help For Some Substance...
The measure cosponsored by Rep. Katherine Clark would offer student loan repayment for participants who agree to work as a treatment professional in areas most in need of their services.
View ArticleHarvard Scientists Aim To Reverse Diabetes With 'Surgery In A Pill'
A team of researchers at Brigham and Women's Hospital is developing a pill that packs the anti-diabetes benefits of weight-loss surgery -- without the operation.
View ArticleThe Science Behind Babies With 3 Parents
A professor in reproductive technologies explains the science behind three-parent babies, and why headlines may misconstrue who counts as a parent.
View ArticleNow We See: How The Opioid Crisis Has Laid Bare Deep Flaws In American Medicine
The physician-fueled opioid crisis, Dr. Elisabeth Poorman writes, is "the result of an effective marketing campaign that has killed hundreds of thousands of people."
View ArticlePills With Embedded Computer Sensors To Treat Mental Illnesses Raise...
A sociologist questions the ethics of Abilify MyCite, an antipsychotic drug with a built-in digital sensor to monitor adherence.
View Article